970 related articles for article (PubMed ID: 1613791)
1. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
[TBL] [Abstract][Full Text] [Related]
2. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
Zagorski MG; Barrow CJ
Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
[TBL] [Abstract][Full Text] [Related]
3. Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.
Barrow CJ; Zagorski MG
Science; 1991 Jul; 253(5016):179-82. PubMed ID: 1853202
[TBL] [Abstract][Full Text] [Related]
4. Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.
Hilbich C; Kisters-Woike B; Reed J; Masters CL; Beyreuther K
J Mol Biol; 1991 Mar; 218(1):149-63. PubMed ID: 2002499
[TBL] [Abstract][Full Text] [Related]
5. Human and rodent Alzheimer beta-amyloid peptides acquire distinct conformations in membrane-mimicking solvents.
Otvos L; Szendrei GI; Lee VM; Mantsch HH
Eur J Biochem; 1993 Jan; 211(1-2):249-57. PubMed ID: 8425535
[TBL] [Abstract][Full Text] [Related]
6. Covalent modification of Alzheimer's amyloid beta-peptide in formic acid solutions.
Orlando R; Kenny PT; Zagorski MG
Biochem Biophys Res Commun; 1992 Apr; 184(2):686-91. PubMed ID: 1575742
[TBL] [Abstract][Full Text] [Related]
7. Conformations of synthetic beta peptides in solid state and in aqueous solution: relation to toxicity in PC12 cells.
Buchet R; Tavitian E; Ristig D; Swoboda R; Stauss U; Gremlich HU; de La Fournière L; Staufenbiel M; Frey P; Lowe DA
Biochim Biophys Acta; 1996 Jan; 1315(1):40-6. PubMed ID: 8611645
[TBL] [Abstract][Full Text] [Related]
8. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
Satheeshkumar KS; Jayakumar R
Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and secondary structural studies of penta(acetyl-Hmb)A beta(1-40).
Clippingdale AB; Macris M; Wade JD; Barrow CJ
J Pept Res; 1999 Jun; 53(6):665-72. PubMed ID: 10408341
[TBL] [Abstract][Full Text] [Related]
10. Free Energy Landscape for Alpha-Helix to Beta-Sheet Interconversion in Small Amyloid Forming Peptide under Nanoconfinement.
Mudedla SK; Murugan NA; Agren H
J Phys Chem B; 2018 Oct; 122(42):9654-9664. PubMed ID: 30253649
[TBL] [Abstract][Full Text] [Related]
11. The N-terminal region of non-A beta component of Alzheimer's disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils.
El-Agnaf OM; Bodles AM; Guthrie DJ; Harriott P; Irvine GB
Eur J Biochem; 1998 Nov; 258(1):157-63. PubMed ID: 9851705
[TBL] [Abstract][Full Text] [Related]
12. Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease.
Shao H; Jao S; Ma K; Zagorski MG
J Mol Biol; 1999 Jan; 285(2):755-73. PubMed ID: 9878442
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the Conformations of Amyloid Beta 42 in Solution That May Mediate Its Initial Hydrophobic Aggregation.
Sonar K; Mancera RL
J Phys Chem B; 2022 Oct; 126(40):7916-7933. PubMed ID: 36179370
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies.
Mandal PK; Pettegrew JW
Neurochem Res; 2004 Dec; 29(12):2267-72. PubMed ID: 15672549
[TBL] [Abstract][Full Text] [Related]
15. Temperature-dependent beta-sheet formation in beta-amyloid Abeta(1-40) peptide in water: uncoupling beta-structure folding from aggregation.
Gursky O; Aleshkov S
Biochim Biophys Acta; 2000 Jan; 1476(1):93-102. PubMed ID: 10606771
[TBL] [Abstract][Full Text] [Related]
16. Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?
Coles M; Bicknell W; Watson AA; Fairlie DP; Craik DJ
Biochemistry; 1998 Aug; 37(31):11064-77. PubMed ID: 9693002
[TBL] [Abstract][Full Text] [Related]
17. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
Satheeshkumar KS; Murali J; Jayakumar R
J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
[TBL] [Abstract][Full Text] [Related]
18. pH-dependent conformations of the amyloid beta(1-28) peptide fragment explored using molecular dynamics.
Kirshenbaum K; Daggett V
Biochemistry; 1995 Jun; 34(23):7629-39. PubMed ID: 7779809
[TBL] [Abstract][Full Text] [Related]
19. Bacterial inclusion bodies of Alzheimer's disease β-amyloid peptides can be employed to study native-like aggregation intermediate states.
Dasari M; Espargaro A; Sabate R; Lopez del Amo JM; Fink U; Grelle G; Bieschke J; Ventura S; Reif B
Chembiochem; 2011 Feb; 12(3):407-23. PubMed ID: 21290543
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the Alzheimer amyloid beta-peptide (1-42) in an apolar microenvironment. Similarity with a virus fusion domain.
Crescenzi O; Tomaselli S; Guerrini R; Salvadori S; D'Ursi AM; Temussi PA; Picone D
Eur J Biochem; 2002 Nov; 269(22):5642-8. PubMed ID: 12423364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
